Collectively, these findings suggest that limonin plays a central role in inhibiting mTOR signaling through AMPK activation, regulating mitochondrial ROS production in IL-17-stimulated keratinocytes, and reducing the expression of psoriasis-related inflammatory factors. This evidence concerns the gene PRKAA1 and psoriasis.